The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Pendrex Plus 4mg/1.25mg Tablets

4 mg/1.25 milligram(s) Tablet

Rowex LtdPA0711/171/001

Main Information

Trade NamePendrex Plus 4mg/1.25mg Tablets
Active SubstancesPerindopril tert-butylamine
Strength4 mg/1.25 milligram(s)
Dosage FormTablet
Licence HolderRowex Ltd
Licence NumberPA0711/171/001

Group Information

ATC CodeC09BA ACE inhibitors and diuretics
C09BA04 perindopril and diuretics


Licence Issued16/07/2010
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0039-011-002
Interchangeable List DocumentPDF of Interchangeable List
« Back